It has also been demonstrated that PCSK9 regulates numerous processes, including hypercholesterolemia and atherosclerosis, vascular inflammation, viral infections, and immune checkpoint regulation in cancer, by targeting other receptors for degradation. Here, PCSK9 is linked to familial hypercholesterolemia.